ACE-IIIBiomarker1 paperIn silico1LatestNov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 2Oct 2026: 16Scientific ReportsIn silico·9 hMachine learning-based multiclass classification of cognitive decline using ACE-III assessment data: a comparative study with SHAP explainabilityBiomarkersMedicineHumans·28 SepAssociation between balance ability and memory function in community-dwelling older adults: A cross-sectional studyPopulationsPLOS OneHumans·11 SepIndividual circulating microRNAs and continuous cognitive performance in a mixed inpatient-outpatient geriatric cohort: A cross-sectional pilot studyBiomarkersCureusHuman trial·20 AugComparison of the Safety and Efficacy of Oral L-arginine for the Treatment of Cognitive Impairment in Older Adults: A Prospective, Randomized, Placebo-Controlled Pilot StudyCognitive impairmentADA Scientific Sessions 2026 AbstractHumans·5 JunCognitive Screening in Older Adults with Type 1 Diabetes: Which Tools Best Detect Potential Cognitive Decline?BiomarkersGSA 2025 AbstractHumans·3 JanIntensity and Domain-Based 24-Hr Activity Patterns Differ in Their Links to Cognitive and Cardiometabolic HealthPopulations
Scientific ReportsIn silico·9 hMachine learning-based multiclass classification of cognitive decline using ACE-III assessment data: a comparative study with SHAP explainabilityBiomarkers
MedicineHumans·28 SepAssociation between balance ability and memory function in community-dwelling older adults: A cross-sectional studyPopulations
PLOS OneHumans·11 SepIndividual circulating microRNAs and continuous cognitive performance in a mixed inpatient-outpatient geriatric cohort: A cross-sectional pilot studyBiomarkers
CureusHuman trial·20 AugComparison of the Safety and Efficacy of Oral L-arginine for the Treatment of Cognitive Impairment in Older Adults: A Prospective, Randomized, Placebo-Controlled Pilot StudyCognitive impairment
ADA Scientific Sessions 2026 AbstractHumans·5 JunCognitive Screening in Older Adults with Type 1 Diabetes: Which Tools Best Detect Potential Cognitive Decline?Biomarkers
GSA 2025 AbstractHumans·3 JanIntensity and Domain-Based 24-Hr Activity Patterns Differ in Their Links to Cognitive and Cardiometabolic HealthPopulations